Crystal structure of bisoprolol fumarate Form I, (C18H32NO4) (C4H2O4)0.5

被引:1
|
作者
Kaduk, James A. [1 ,2 ]
Gindhart, Amy M. [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
bisoprolol fumarate; Zebeta; powder diffraction; Rietveld refinement; density functional theory; DIFFRACTION; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715619000757
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of bisoprolol fumarate Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Bisoprolol fumarate Form I crystallizes in space group P-1 (#2) with a = 8.165 70(5) angstrom, b = 8.516 39(12) angstrom, c = 16.751 79(18) angstrom, alpha = 89.142(1)degrees, beta = 78.155(1)degrees, gamma = 81.763(1)degrees, V = 1128.265(10) angstrom(3), and Z = 2. The neutral side chain of the bisoprolol cation is probably disordered. The cation and anion are linked by N-H center dot center dot center dot O and O-H center dot center dot center dot O hydrogen bonds. The cations are also linked by N-H center dot center dot center dot O hydrogen bonds. The result is alternating layers of hydrophilic and hydrophobic layers parallel to the ab-plane. The density of the structure is relatively low at 1.130 g cm(-3), but there are no obvious voids in the structure. The powder pattern is included in the Powder Diffraction File (TM) as entry 00-066-1625. (C) 2019 International Centre for Diffraction Data.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [21] Crystal structure of toceranib, C22H25FN4O2
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 21 - 26
  • [22] Crystal structure of pantoprazole sodium sesquihydrate Form I, C16H14F2N3O4SNa(H2O)1.5
    Gonzalez, Diana
    Golab, Joseph T.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (01) : 53 - 60
  • [23] Crystal structure of alfuzosin hydrochloride, C19H28N5O4Cl
    Kaduk, James A.
    POWDER DIFFRACTION, 2022, 37 (03) : 171 - 182
  • [24] Crystal structure of aminopentamide hydrogen sulfate, (C19H25N2O)(HSO4)
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 200 - 205
  • [25] Crystal structure of indacaterol hydrogen maleate (C24H29N2O3)(HC4H2O4)
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (02) : 76 - 81
  • [26] Crystal structure of choline fenofibrate (Trilipix®), (C5H14NO) (C17H14ClO4)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 142 - 148
  • [27] Crystal structure of sitagliptin dihydrogen phosphate monohydrate, C16H16F6N5O(H2PO4)(H2O)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (04) : 349 - 356
  • [28] Crystal structure of hydrocortisone acetate, C23H32O6
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2017, 32 (01) : 31 - 34
  • [29] Crystal structure of levocetirizine dihydrochloride Form I, C21H27ClN2O3Cl2
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (03) : 181 - 189
  • [30] Crystal structure of atropine sulfate monohydrate, (C17H24NO3)2(SO4)•(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (04) : 389 - 395